https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/construction-underway-zayed-centre-featuring-new-cleanrooms-production-gene-and-cell-therapy/
Construction underway of Zayed Centre featuring new ‘cleanrooms’ for the production of gene and cell therapy medicinal products
16 Sep 2016, 11:06 a.m.
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be made to treat children compassionately or on a clinical trial.
Currently GOSH has two ‘cleanrooms’ which are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) as compliant with “Good Manufacturing Practice (GMP)” and one ‘cleanroom’ for routine bone marrow manipulations licensed by the Human Tissue Authority (HTA). However, these rooms are close to maximum capacity at present. As so many new advanced therapy products are being developed to treat an ever wider range of diseases, the new ZCR GMP will provide essential new capacity by 2018, when the facility opens. It is not easy to predict exactly what new treatments will become available, but so far these include: severe combined immunodeficiencies, different types of leukaemia, whole tumours, skin disorders and viral infection post bone marrow transplant.
New plan announced to get more children access to gene therapy treatments
Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.
Patients, families, clinicians and researchers learn together on rare blinding condition
Last December, the Norrie Disease conference took place at University College London, Great Ormond Street Institute of Child Health, organised by the Norrie Disease Foundation and Professor Jane Sowden’s research group.
GOSH patient receives world-first treatment for her 'incurable' T-cell leukaemia
In May 2022, Alyssa, 13 from Leicester, became the first reported patient in the world to receive base-edited T-cells at Great Ormond Street Hospital for Children (GOSH), in collaboration with the UCL Great Ormond Street Institute of Child Health (UCL GOS
Celebrating three years of progress and breakthroughs at the ZCR
We're celebrating three years of the Zayed Centre for Research. That's another year of breakthrough research, with hundreds of clinicians and researchers collaborating to help seriously ill children from across the globe.